Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on Ipatasertib PK in Healthy Subjects
NCT03222310Phase 1Completed
- Sponsor
- Roche
- Start
- Jul 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ipatasertib in solid tumor, sponsored by Roche. Primary endpoints: Maximum Observed Plasma Concentration at Day 19, Area Under the Plasma Concentration-Time Curve From Time Zero to Extrapolated Infinite Time at Day 19 and 1 more. Started Jul 2017; status: completed.
02
Drugs
ipatasertib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03222310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03222310.